Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

Signature(s)

Amount
€ 35,440,000
Countries
Sector(s)
Romania : € 35,440,000
Services : € 10,277,600
Education : € 25,162,400
Signature date(s)
17/06/2024 : € 10,277,600
17/06/2024 : € 25,162,400

Summary sheet

Release date
8 July 2024
Status
Reference
Signed | 17/06/2024
20220866
Project name
Promoter - financial intermediary
IASI UNIVERSITY OF MEDICINE AND PHARMACY
UNIVERSITATEA DE MEDICINA SI FARMACIE GRIGORE T. POPA IASI
Proposed EIB finance (Approximate amount)
Total cost (Approximate amount)
EUR 35 million
EUR 71 million
Location
Sector(s)
Description
Objectives

The project concerns the construction and refurbishment of a number of facilities on the university campus of the Grigore T. Popa Medicine and Pharmacy University of Iasi.

The project will finance the construction, extension, renovation and rehabilitation of university premises in Romania. The main objective is to provide better learning conditions for students, as well as improved working and research conditions for university staff, by creating additional capacity in academic and research buildings and by renovating existing spaces that are no longer fit for purpose. These investments are also aimed at adapting infrastructures to new technologies, providing additional or modernised student accommodation, improving accessibility for people with disabilities, and also improving the energy efficiency of buildings. All building construction and renovation projects will be energy efficient and will follow energy efficiency standards. The final beneficiaries for this project are current and future students, as well as university staff.

Additionality and Impact

The Project addresses a sub-optimal situation with regard to investments in higher education infrastructure in Romania. Public higher education has the nature of a public good for which the operator cannot capture sufficient financial benefits, justifying public intervention. The Project also addresses a market failure with regard to the financing of infrastructure for early-stage R&D activities performed in public higher education institutions. The markets fail to provide adequate funds for early-stage R&D because of the uncertainty inherent in these activities and because of knowledge spillovers, which reduce the appropriability of economic returns. The Project will create new space for teaching and research, will invest in modern educational equipment, and will provide modern accommodation and support infrastructure for students at University of Medicine and Pharmacy "Grigore T. Popa". These measures can be expected to increase the quality and relevance of higher education and research in Romania's North-East region and contribute to increasing the region's capacity to innovate. The Project also addresses the need for energy efficiency upgrades of several faculty buildings. EIB involvement is expected to crowd in further funding for University of Medicine and Pharmacy "Grigore T. Popa". The University benefitted from the support of the InvestEU Advisory for Social Infrastructure and Service (technical and financial advisory from internal experts and external consultants).

Environmental aspects
Procurement

The Directive 2011/92/EU amended by 2014/52/EU does not specifically mention the need for an Environmental Impact Assessment (EIA) for buildings relating to education, but it may be that some sub-projects can be regarded as urban renewal projects (Annex II of the European Directive). This will be verified for each sub-operation during the appraisal. Directive 2010/31/EU amended in 2018 by Directive (EU) 2018/844 on the Energy Performance of Buildings will be checked during appraisal for each component on a case-by-case basis.

The Bank will require the Promoter to ensure that contracts for the implementation of the project shall be tendered in accordance with the relevant applicable EU procurement legislation, Directive 2014/24/EU as well as Directive 89/665/EEC as interpreted by the Court of Justice of the EU, with publication of tender notices in the EU Official Journal, as and where required.

Milestone
Under appraisal
Approved
Signed
27 October 2023
17 June 2024
Related projects
Link to source

Disclaimer

Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

Documents

Environmental and Social Data Sheet (ESDS) - IASI UNIVERSITY OF MEDICINE AND PHARMACY
Publication Date
19 Jul 2024
Document language
Main Topic
Lending
Document Number
170792182
Document Focus
Environmental Information
Project Number
20220866
Sector(s)
Regions
Countries
Publicly available
Download now

News & Stories

General enquiries and comments

The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

Media enquiries

Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

Complaints mechanism

Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

Zero tolerance against fraud and corruption

The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

Related publications